Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Glucotrack (GCTK) Free Cash Flow (2016 - 2020)

Glucotrack's Free Cash Flow history spans 7 years, with the latest figure at -$851000.0 for Q4 2020.

  • For the quarter ending Q4 2020, Free Cash Flow fell 6.78% year-over-year to -$851000.0, compared with a TTM value of -$3.6 million through Dec 2020, up 9.38%, and an annual FY2025 reading of -$15.3 million, down 21.77% over the prior year.
  • Free Cash Flow for Q4 2020 was -$851000.0 at Glucotrack, down from -$796000.0 in the prior quarter.
  • The five-year high for Free Cash Flow was -$510336.0 in Q1 2016, with the low at -$2.5 million in Q2 2017.
  • Average Free Cash Flow over 5 years is -$1.2 million, with a median of -$1.1 million recorded in 2019.
  • Year-over-year, Free Cash Flow tumbled 124.87% in 2017 and then skyrocketed 58.74% in 2018.
  • Tracing GCTK's Free Cash Flow over 5 years: stood at -$1.5 million in 2016, then skyrocketed by 47.04% to -$788005.0 in 2017, then crashed by 38.54% to -$1.1 million in 2018, then increased by 27.0% to -$796938.0 in 2019, then decreased by 6.78% to -$851000.0 in 2020.
  • Per Business Quant, the three most recent readings for GCTK's Free Cash Flow are -$851000.0 (Q4 2020), -$796000.0 (Q3 2020), and -$903000.0 (Q2 2020).